• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Immune cells-derived exosomes: A promising strategy for COVID-19 treatment.

作者信息

Zhang Zichen, Long Jiangang, Meng Lingjie, Yang Zhiwei, Zhang Shengli, Zhang Lei

机构信息

MOE Key Laboratory for Nonequilibrium Synthesis and Modulation of Condensed Matter, School of Physics Xi'an Jiaotong University Xi'an China.

School of Life Science and Technology Xi'an Jiaotong University Xi'an China.

出版信息

Clin Transl Discov. 2022 Oct 10;2(4):e138. doi: 10.1002/ctd2.138. eCollection 2022 Dec.

DOI:10.1002/ctd2.138
PMID:36712172
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9874742/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb78/9874742/7e3b7c701b47/CTD2-2-e138-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb78/9874742/7e3b7c701b47/CTD2-2-e138-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb78/9874742/7e3b7c701b47/CTD2-2-e138-g001.jpg

相似文献

1
Immune cells-derived exosomes: A promising strategy for COVID-19 treatment.免疫细胞衍生的外泌体：一种有前景的 COVID-19 治疗策略。
Clin Transl Discov. 2022 Oct 10;2(4):e138. doi: 10.1002/ctd2.138. eCollection 2022 Dec.
2
A novel nano therapeutic using convalescent plasma derived exosomal (CP) for COVID-19: A combined hyperactive immune modulation and diagnostics.一种使用恢复期血浆来源外泌体（CP）治疗COVID-19的新型纳米疗法：兼具过度活跃免疫调节与诊断功能。
Chem Biol Interact. 2021 Aug 1;344:109497. doi: 10.1016/j.cbi.2021.109497. Epub 2021 May 13.
3
Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections.免疫细胞衍生的外泌体在治疗 SARS-CoV-2 感染方面的应用前景广阔。
Clin Transl Med. 2022 Aug;12(8):e1026. doi: 10.1002/ctm2.1026.
4
Released Exosomes Contribute to the Immune Modulation of Cord Blood-Derived Stem Cells.释放的外泌体有助于调节脐血来源的干细胞的免疫功能。
Front Immunol. 2020 Feb 25;11:165. doi: 10.3389/fimmu.2020.00165. eCollection 2020.
5
Mesenchymal Stem Cell Derived-Exosomes as Effective Factors in Reducing Cytokine Storm Symptoms of COVID-19.间充质干细胞衍生的外泌体可作为减轻 COVID-19 细胞因子风暴症状的有效因子。
Protein Pept Lett. 2021;28(8):945-952. doi: 10.2174/0929866528666210222150347.
6
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.携带外源性干扰RNA混合物的间充质干细胞衍生外泌体在新冠疫情爆发时代是一种前所未有的治疗方法。
J Transl Med. 2021 Apr 22;19(1):164. doi: 10.1186/s12967-021-02840-3.
7
Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.间充质干细胞及其衍生的外泌体对 COVID-19 治疗的免疫调节作用。
BMB Rep. 2020 Aug;53(8):400-412. doi: 10.5483/BMBRep.2020.53.8.121.
8
Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response.从 COVID-19 患者血浆中回收的外泌体暴露了 SARS-CoV-2 刺突衍生片段，并有助于适应性免疫反应。
Front Immunol. 2022 Jan 17;12:785941. doi: 10.3389/fimmu.2021.785941. eCollection 2021.
9
COVID-19 plasma exosomes promote proinflammatory immune responses in peripheral blood mononuclear cells.COVID-19 血浆外泌体促进外周血单核细胞的促炎免疫反应。
Sci Rep. 2022 Dec 16;12(1):21779. doi: 10.1038/s41598-022-26457-8.
10
Mesenchymal Stromal/Stem Cells-Derived Exosomes as an Antimicrobial Weapon for Orodental Infections.间充质基质/干细胞衍生的外泌体作为口腔感染的抗菌武器
Front Microbiol. 2022 Jan 4;12:795682. doi: 10.3389/fmicb.2021.795682. eCollection 2021.

引用本文的文献

1
Exosomes: Potential Next-Generation Nanocarriers for the Therapy of Inflammatory Diseases.外泌体：炎症性疾病治疗中潜在的下一代纳米载体
Pharmaceutics. 2023 Sep 4;15(9):2276. doi: 10.3390/pharmaceutics15092276.

本文引用的文献

1
Promising use of immune cell-derived exosomes in the treatment of SARS-CoV-2 infections.免疫细胞衍生的外泌体在治疗 SARS-CoV-2 感染方面的应用前景广阔。
Clin Transl Med. 2022 Aug;12(8):e1026. doi: 10.1002/ctm2.1026.
2
SARS-CoV-2-specific T cell responses and immune regulation in infected pregnant women.新型冠状病毒特异性 T 细胞应答与感染孕妇的免疫调控。
J Reprod Immunol. 2022 Feb;149:103464. doi: 10.1016/j.jri.2021.103464. Epub 2021 Dec 11.
3
Exosome-mediated stable epigenetic repression of HIV-1.外泌体介导的 HIV-1 的稳定表观遗传抑制。
Nat Commun. 2021 Sep 20;12(1):5541. doi: 10.1038/s41467-021-25839-2.
4
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak.携带外源性干扰RNA混合物的间充质干细胞衍生外泌体在新冠疫情爆发时代是一种前所未有的治疗方法。
J Transl Med. 2021 Apr 22;19(1):164. doi: 10.1186/s12967-021-02840-3.
5
A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood.一项关于 COVID-19 感染外周血差异 circRNA 和 lncRNA 表达的研究。
Sci Rep. 2021 Apr 12;11(1):7991. doi: 10.1038/s41598-021-86134-0.
6
COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?COVID-19 治疗采用间充质基质细胞（MSC）和恢复期血浆必须考虑外泌体的参与：恢复期血浆中的外泌体是否拮抗了微弱的免疫抗体？
J Extracell Vesicles. 2020 Oct;10(1):e12004. doi: 10.1002/jev2.12004. Epub 2020 Nov 14.
7
MicroRNA-206 inhibits influenza A virus replication by targeting tankyrase 2.微小 RNA-206 通过靶向端锚聚合酶 2 抑制甲型流感病毒复制。
Cell Microbiol. 2021 Feb;23(2):e13281. doi: 10.1111/cmi.13281. Epub 2020 Nov 4.
8
COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup.COVID-19 相关急性肾损伤：第 25 届急性疾病质量倡议（ADQI）工作组的共识报告。
Nat Rev Nephrol. 2020 Dec;16(12):747-764. doi: 10.1038/s41581-020-00356-5. Epub 2020 Oct 15.
9
Mesenchymal stem cells and exosome therapy for COVID-19: current status and future perspective.间充质干细胞和外泌体治疗 COVID-19：现状和未来展望。
Hum Cell. 2020 Oct;33(4):907-918. doi: 10.1007/s13577-020-00407-w. Epub 2020 Aug 11.
10
Surface functionalization of exosomes for target-specific delivery and in vivo imaging & tracking: Strategies and significance.外泌体的表面功能化用于靶向递药和体内成像及跟踪：策略与意义。
J Control Release. 2020 Oct 10;326:599-614. doi: 10.1016/j.jconrel.2020.07.042. Epub 2020 Jul 28.